<DOC>
	<DOC>NCT02090803</DOC>
	<brief_summary>The purpose of this study is to assess the human herpes virus reactivation 6 post autologous stem cells in 196 patients. The aim of our study was to describe the incidence of reactivation of HHV-6 in patients requiring autologous HSCT and determine the pathogenic role in this target population.</brief_summary>
	<brief_title>Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Diseases</mesh_term>
	<criteria>all patients hospitalized in the Hematology Clinic of SaintEtienne and ClermontFerrand and receiving autologous hematopoietic stem cells, according to the decision of the Consultative Meeting Multidisciplinary service; Autologous recipients are included irrespective of causal hemopathy (myeloma, lymphoma, acute leukemia, mainly). The nonconsenting patients or unable to give consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>